Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-09-07

Clinical Trial Update: Additive Renoprotective Effects of Oral Calcitriol in IgA Nephropathy Patients Taking Renin-Angiotensin System Blockers [NA]

View source ↗

Summary

A completed clinical trial assessed whether adding oral calcitriol provides additional renoprotective effects for patients with IgA nephropathy already on renin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Calcitriol (calcitriol)

Snippet

Sponsor: Yonsei University | Conditions: IgA Nephropathy | NA | Status: COMPLETED